Safety and tolerability of adjunctive brivaracetam as intravenous infusion or bolus in patients with epilepsy.
Saved in:
| Title: | Safety and tolerability of adjunctive brivaracetam as intravenous infusion or bolus in patients with epilepsy. |
|---|---|
| Authors: | Klein P; Mid-Atlantic Epilepsy and Sleep Center, Bethesda, Maryland, U.S.A., Biton V; Arkansas Epilepsy Program, Little Rock, Arkansas, U.S.A., Dilley D; UCB Pharma, Raleigh, North Carolina, U.S.A., Barnes M; UCB Pharma, Raleigh, North Carolina, U.S.A., Schiemann J; UCB Pharma, Raleigh, North Carolina, U.S.A., Lu S; UCB Pharma, Raleigh, North Carolina, U.S.A. |
| Source: | Epilepsia [Epilepsia] 2016 Jul; Vol. 57 (7), pp. 1130-8. Date of Electronic Publication: 2016 May 25. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Blackwell Science Country of Publication: United States NLM ID: 2983306R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-1167 (Electronic) Linking ISSN: 00139580 NLM ISO Abbreviation: Epilepsia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1528-1167 |
|---|---|
| DOI: | 10.1111/epi.13409 |
